Kry (Livi) operates in telehealth / digital healthcare. Its most recent disclosed valuation is $2B. The stock is not listed on any public market.
1 valuation. The latest, $2B post-money, was set by the unnamed (Apr 2021) in Apr 2021.
AccelLEADSSequoia CapitalOothersKry is a digital-first healthcare provider that delivers primary and specialist care through a mobile and web app, connecting patients with doctors, nurses, psychologists and physiotherapists over video and chat, alongside a network of physical clinics. The company trades as Kry in Sweden, Norway and Germany and as Livi in the United Kingdom and France. Its product suite spans the patient app, the Kry Pro clinician record system used by its medical staff, and a backoffice tool for business operations. Kry was founded in Stockholm in 2015 by Johannes Schildt.
Beyond consumer bookings, Kry sells digital clinical capacity to public payers such as the NHS and Swedish regions, employers, insurers and Employee Assistance Programmes, and reports more than 14 million patient appointments delivered by over 4,000 healthcare professionals across 60-plus clinics.
Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Kry (Livi).
Often trade at a premium or discount to NAV.
Platforms match existing holders with buyers. Kry (Livi) availability at any moment is set by the holders.
High minimums, transfer approval, company right-of-first-refusal.
Valuations, rounds and IPO status for every company in the directory — Kry (Livi) included.
Lead investors for each round are in the funding timeline.
The closest telehealth / digital healthcare peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Kry (Livi) is a private company; its shares do not trade on a public exchange.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
